secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tvardi Therapeutics, Inc. (TVRD)
CIK:        0001346830
Form:       8-K
Filed at:   2024-02-02T23:59:59+00:00
Accession:  0001104659-24-010123
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Cara Therapeutics receives Nasdaq non-compliance notice for bid price below $1.00 per share
--------------------------------------------------------------------------------

- Nasdaq notified Cara on Feb 1, 2024 that its common stock bid price was below $1.00 for 30 consecutive business days.
- Company has 180 calendar days, until July 30, 2024, to regain compliance by closing at $1.00+ for 10 consecutive days.
- If not compliant by July 30, Cara may transfer to Nasdaq Capital Market for an additional 180-day cure period.
- Failure to regain compliance could result in delisting from The Nasdaq Global Select Market.
- Cara intends to monitor its stock price and consider available options, but no assurance of regaining compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1346830/000110465924010123/0001104659-24-010123-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1346830/000110465924010123/tm245054d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-010123

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer